DeSC Healthcare Database (Japan)
DeSC Healthcare, Inc.
RWE Promotion Department
JAPAN
Email: rwe-psales@desc-hc.co.jp
N/A
1. Kamitani F, Nishioka Y, Koizumi M, Nakajima H, Kurematsu Y, Okada S, Kubo S, Myojin T, Noda T, Imamura T, Takahashi Y. Immune checkpoint inhibitor-related type 1 diabetes incidence, risk, and survival association. J Diabetes Investig. 2025 Feb;16(2):334-342.
2. Masuda S, Fukasawa T, Matsuda S, Kawakami K. Cardiovascular Safety and Fracture Prevention Effectiveness of Denosumab Versus Oral Bisphosphonates in Patients Receiving Dialysis : A Target Trial Emulation. Ann Intern Med. 2025 Feb;178(2):167-176.
3. Inayama Y, Yamaguchi K, Mizuno K, Tanaka-Mizuno S, Koike A, Higashiyama N, Taki M, Yamanoi K, Murakami R, Hamanishi J, Yoshida S, Mandai M, Kawakami K. Changes in Physical Activity Across Cancer Diagnosis and Treatment Based on Smartphone Step Count Data Linked to a Japanese Claims Database: Retrospective Cohort Study. JMIR Cancer. 2025 Jan 20;11:e58093.
4. Tominaga R, Ikenoue T, Ishii R, Niihata K, Aita T, Okuda T, Shimizu S, Taguri M, Kurita N. Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis: a new-user, active comparator design with instrumental variable analyses. J Bone Miner Res. 2025 Jan 17:zjaf010. doi: 10.1093/jbmr/zjaf010. Epub ahead of print.
5. Ikeda Y, Yamamoto T, Torigoe M, Casaes Teixeira B, Laurent T. Prevalence, Patient Characteristics, and Treatment of Patients with Hypertrophic Cardiomyopathy: A Nationwide Payer Database Study. Cardiol Ther. 2025 Jan 15. doi: 10.1007/s40119-024-00396-z. Epub ahead of print.
6. Horinouchi H, Chang CS, Shaw J, Archangelidi O, Balasubramanian A, Pundole X. Real-world treatment patterns and survival in extensive stage small-cell lung cancer in Japan. Jpn J Clin Oncol. 2024 Dec 20:hyae175. doi: 10.1093/jjco/hyae175. Epub ahead of print.
7. Satoh M, Nakayama S, Hashimoto H, Toyama M, Iwabe Y, Yagihashi T, Murakami T, Obara T, Ohkubo T, Metoki H. Differential coronary heart disease risk among antihypertensive and lipid-lowering medication users versus non-users: A real-world data analysis. J Clin Lipidol. 2024 Dec 16:S1933-2874(24)00288-5. doi: 10.1016/j.jacl.2024.12.006. Epub ahead of print.
8. Okura T, Tanaka-Mizuno S, Fukasawa T, Yoshida S, Kawakami K. Assessing the Risk of Gastrointestinal Perforation Associated with COVID-19: A Self-Controlled Case Series Study. Am J Epidemiol. 2024 Dec 10:kwae448. doi: 10.1093/aje/kwae448. Epub ahead of print.
9. Matsumura K, Nakagomi A, Yagi E, Yamada N, Funauchi Y, Kakehi K, Yoshida A, Kawamura T, Ueno M, Nakazawa G, Tabuchi T. Impact of an mHealth App (Kencom) on Patients With Untreated Hypertension Initiating Antihypertensive Medications: Real-World Cohort Study. JMIR cardio. 2024 Nov 26;8(1):e52266.
10. Karasawa Y, Nozawa K, Nomoto K, Fukudo S. Constipation among workers with depression/anxiety: a retrospective study using a claims database and survey data in Japan. BMJ Open. 2024 Nov 19;14(11):e083668.